Dec 12, 2016 12:30 pm UTC| Business
NIWOT, Colo., Dec. 12, 2016 -- Crocs, Inc. (NASDAQ:CROX) today announced that entertainment superstars Drew Barrymore, John Cena, YOONA and Henry Lau will serve as global ambassadors in the brand’s “Come As You Are”...
United Pacific Selects Cardtronics for ATM Services
Dec 12, 2016 12:30 pm UTC| Business
HOUSTON, Dec. 12, 2016 -- Cardtronics (Nasdaq:CATM) today announced a long-term agreement with United Pacific, which has named Cardtronics its exclusive provider of ATM services covering more than 300 gas station and...
Communications Sales & Leasing, Inc. Announces Launch of Notes Offering
Dec 12, 2016 12:16 pm UTC| Business
LITTLE ROCK, Ark., Dec. 12, 2016 -- Communications Sales Leasing, Inc. (“CSL” or the “Company”) and CSL Capital, LLC (the “Co-Issuer” and, together with CSL, the “Issuers”) announced today the planned offering, subject...
Galena Biopharma Presented Two Posters at the San Antonio Breast Cancer Symposium
Dec 12, 2016 12:05 pm UTC| Business
NeuVax™ (nelipepimut-S) Phase 2 VADIS trial design in women with ductal carcinoma in situ (DCIS)GALE-301 and GALE-302 Phase 1b clinical data in breast cancer patients SAN RAMON, Calif., Dec. 12, 2016 -- Galena...
Achaogen Announces Positive Results in Phase 3 cUTI and CRE Clinical Trials of Plazomicin
Dec 12, 2016 12:01 pm UTC| Business
-- EPIC registration trial successfully achieves FDA primary endpoints in patients with complicated urinary tract infections (cUTI) -- -- EPIC demonstrates superiority on EMA primary endpoints -- -- CARE descriptive...
Achaogen Announces Positive Results in Phase 3 cUTI and CRE Clinical Trials of Plazomicin
Dec 12, 2016 12:01 pm UTC| Business
-- EPIC registration trial successfully achieves FDA primary endpoints in patients with complicated urinary tract infections (cUTI) -- -- EPIC demonstrates superiority on EMA primary endpoints -- -- CARE descriptive...
Inspyr Announces Private Placement of $1.0 Million
Dec 12, 2016 12:00 pm UTC| Business
WESTLAKE VILLAGE, Calif., Dec. 12, 2016 -- Inspyr Therapeutics (OTCQB:NSPX) (“Inspyr” or the “Company”), a biotech company developing novel prodrug therapeutics for the treatment of cancer, today announced that it has...